In the present study, we observed that those mice receiving intraperitoneal administration of low-dose HMGN1 with αCD4 had an increasing number of tumor-infiltrating CD8+ T cells with the less exhausted phenotypes and the capacity to produce multiple cytokines. This evidence concerns the gene HMGN1 and neoplasm.